These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1620707)

  • 21. Hepatocarcinogenic susceptibility of rasH2 mice to troglitazone in a two-stage hepatocarcinogenesis model.
    Jin M; Saekusa Y; Dewa Y; Nishimura J; Matsumoto S; Shibutani M; Hasumi K; Mitsumori K
    Arch Toxicol; 2009 Feb; 83(2):173-81. PubMed ID: 18597072
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cell biology of hepatocarcinogenesis.
    Saeter G; Seglen PO
    Crit Rev Oncog; 1990; 1(4):437-66. PubMed ID: 1964598
    [No Abstract]   [Full Text] [Related]  

  • 23. Hepatocarcinogenesis in the rat: the effect of promoters and carcinogens in vivo and in vitro.
    Moore MA; Kitagawa T
    Int Rev Cytol; 1986; 101():125-73. PubMed ID: 3009348
    [No Abstract]   [Full Text] [Related]  

  • 24. Tumor promotion in the liver.
    Schulte-Hermann R
    Arch Toxicol; 1985 Aug; 57(3):147-58. PubMed ID: 3904674
    [No Abstract]   [Full Text] [Related]  

  • 25. Minimal neoplasias in experimental liver carcinogenesis.
    Rabes HM
    Recent Results Cancer Res; 1988; 106():21-7. PubMed ID: 3285413
    [No Abstract]   [Full Text] [Related]  

  • 26. Liver carcinogenesis associated with feeding of ethionine in a choline-free diet: evidence against a role of oval cells in the emergence of hepatocellular carcinoma.
    Tarsetti F; Lenzi R; Salvi R; Schuler E; Rijhsinghani K; Lenzen R; Tavoloni N
    Hepatology; 1993 Sep; 18(3):596-603. PubMed ID: 8359801
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differences between the promoting activities of the peroxisome proliferator WY-14,643 and phenobarbital in rat liver.
    Cattley RC; Popp JA
    Cancer Res; 1989 Jun; 49(12):3246-51. PubMed ID: 2566380
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitative analysis of enzyme-altered foci in rat hepatocarcinogenesis experiments--I. Single agent regimen.
    Moolgavkar SH; Luebeck EG; de Gunst M; Port RE; Schwarz M
    Carcinogenesis; 1990 Aug; 11(8):1271-8. PubMed ID: 2143703
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Liver cell cancer: insights into the pathogenesis of hepatocellular carcinoma in humans from experimental hepatocarcinogenesis in the rat.
    Farber E
    Monogr Pathol; 1987; (28):199-222. PubMed ID: 3023976
    [No Abstract]   [Full Text] [Related]  

  • 30. Proton NMR studies of tissue water phases during chemical carcinogenesis in rats.
    Pouliquen D; Rivet P; Gallier J; Le Jeune JJ; De Certaines JD
    Anticancer Res; 1993; 13(1):49-55. PubMed ID: 8386495
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The significance of preneoplastic liver lesions in experimental animals.
    Williams GM
    Adv Vet Sci Comp Med; 1987; 31():21-44. PubMed ID: 3300203
    [No Abstract]   [Full Text] [Related]  

  • 32. Possible involvement of oxidative stress in fenofibrate-induced hepatocarcinogenesis in rats.
    Nishimura J; Dewa Y; Okamura T; Muguruma M; Jin M; Saegusa Y; Umemura T; Mitsumori K
    Arch Toxicol; 2008 Sep; 82(9):641-54. PubMed ID: 18253720
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of dose and duration of administration on the promotion index of phenobarbital in multistage hepatocarcinogenesis in the rat.
    Rizvi TA; Kennan W; Xu YH; Pitot HC
    APMIS Suppl; 1988; 2():262-74. PubMed ID: 3179034
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemical carcinogenesis: the liver as a model.
    Farber E; Sarma DS
    Pathol Immunopathol Res; 1986; 5(1):1-28. PubMed ID: 3022277
    [No Abstract]   [Full Text] [Related]  

  • 35. Lack of carcinogenicity of daminozide, alone or in combination with its contaminant 1,1-dimethylhydrazine, in a medium-term bioassay.
    Cabral R; Hakoi K; Hoshiya T; Hasegawa R; Ito N
    Teratog Carcinog Mutagen; 1995-1996; 15(6):307-12. PubMed ID: 8732881
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of FK 506 on experimental liver carcinogenesis.
    Shinozuka H; Warty VS; Masuhara M; Murase N; Iwatsuki S
    Transplant Proc; 1991 Dec; 23(6):3197-9. PubMed ID: 1721407
    [No Abstract]   [Full Text] [Related]  

  • 37. The role of somatic mutations and cell replication kinetics in quantitative cancer risk assessment.
    Moolgavkar SH; Luebeck EG
    Prog Clin Biol Res; 1991; 369():469-79. PubMed ID: 1835095
    [No Abstract]   [Full Text] [Related]  

  • 38. Characterization of the stage of progression in hepatocarcinogenesis in the rat.
    Pitot HC
    Basic Life Sci; 1991; 57():3-18. PubMed ID: 1814289
    [No Abstract]   [Full Text] [Related]  

  • 39. The prevention of chemical hepatocarcinogenesis in rats by combining active and passive immunization with alpha-fetoprotein.
    Kamata Y
    Tumour Biol; 1985; 6(3):243-56. PubMed ID: 2416033
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhancement of hepatocarcinogenesis in rainbow trout with carbon tetrachloride.
    Kotsanis N; Metcalfe CD
    Bull Environ Contam Toxicol; 1991 Jun; 46(6):879-86. PubMed ID: 1863795
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.